New Research Directions that Advance the NHLBI Strategic Vision Normal Biology (R21 - Clinical Trial Not Allowed)
ArchivedNational Institutes of Health
Description
The development of more effective means for diagnosing and treating heart, lung, blood, and sleep (HLBS) disorders is often aided bya detailed understanding of normal biology, specifically the nature and operations of the molecular systems and cells that are affected by those diseases. ?Areas of?r?e?s?e?a?r?c?h? ?i?n?t?e?r?e?s?t?include? ?s?t?u?d?i?e?s? ?o?f? ?f?u?n?d?a?m?e?n?t?a?l? ?p?r?o?c?e?s?s?e?s? ?t?h?a?t?explain resilience the capability of some individuals to maintain or restore normal function despite aging or exposurethat causes disease in others.This Program Announcement FOA will support pilot studies by R01-funded investigators in areas of research that advance high priority studies of normal biology and resilience as described by Objective 1 of the NHLBI Strategic Vision.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Contact
NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV
FBOWebmaster@OD.NIH.GOV
- PostedNov 1, 2018
- ClosesJan 7, 2022
- Award ceiling$200,000
- CFDA93.233, 93.837, 93.838, 93.839, 93.840
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro